The Current State of Clinical Study Startup
Posted by Michael Jay on Wed, Jan 26, 2011
RxTrials welcomes Erik Sam and Dan Manak with goBalto as guest bloggers who wrote the post below:
Clinical study startup (SSU) has consistently been referred to as the “bottleneck” in any clinical trial. This entire process of identifying sites, exchanging CDAs, questionnaires, regulatory documents, and the endless back and forth that takes place between sponsors, CROs, and sites has been described as “one giant mess.” Sponsors have a difficult time finding the right sites and initiating them in a timely manner. more...